OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 72 filers reported holding OCULAR THERAPEUTIX INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $151 | -99.8% | 22,088 | +48.4% | 0.00% | – |
| Q1 2022 | $74,000 | -26.0% | 14,884 | +4.1% | 0.00% | – |
| Q4 2021 | $100,000 | -2.9% | 14,303 | +38.7% | 0.00% | -100.0% |
| Q3 2021 | $103,000 | +1044.4% | 10,314 | +498.6% | 0.00% | – |
| Q2 2016 | $9,000 | -40.0% | 1,723 | +14.1% | 0.00% | – |
| Q1 2016 | $15,000 | +36.4% | 1,510 | +28.1% | 0.00% | – |
| Q4 2015 | $11,000 | -47.6% | 1,179 | -22.5% | 0.00% | – |
| Q3 2015 | $21,000 | +320.0% | 1,522 | +513.7% | 0.00% | – |
| Q2 2015 | $5,000 | – | 248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,784,850 | $15,064,000 | 62.56% |
| Versant Venture Management, LLC | 2,215,384 | $8,817,228,000 | 4.36% |
| SV Health Investors, LLC | 628,236 | $2,500,000 | 1.54% |
| DELTEC ASSET MANAGEMENT LLC | 724,747 | $2,885,000 | 0.80% |
| Endurant Capital Management LP | 232,727 | $926,000 | 0.49% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $1,011,000 | 0.15% |
| JGP Global Gestao de Recursos Ltda. | 12,568 | $50,000 | 0.06% |
| Man Group plc | 1,187,508 | $4,726,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 21,077 | $84,000 | 0.02% |
| NewEdge Advisors, LLC | 36,250 | $144,000 | 0.01% |